Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Open PHACTS - the use of open data for in silico models

Gerhard Ecker
20th EuroQSAR
Conference, Talk or oral contribution
4.9.2014 - 4.9.2014

Exploiting integrated open data in drug discovery

Gerhard Ecker
Drug Discovery Summit - Drug Design and Medicinal Chemistry
Conference, Talk or oral contribution
9.5.2014 - 9.5.2014

It's all about integration - From docking poses to structure-based classification and prediction of side effects

Gerhard Ecker
Chemical Computing Group UGM & Conference 2014 - Europe
Conference, Talk or oral contribution
25.4.2014 - 25.4.2014

Open PHACTS - Building an open pharmacological space

Gerhard Ecker
Spring Meeting of the Swiss Society of Pharmacology and Toxicology
Conference, Talk or oral contribution
3.4.2014 - 3.4.2014

Analyse der molekularen Basis der GABA Transporter Inhibition

Andreas Jurik , Barbara Zdrazil , Marion Holy , Harald H. Sitte , Gerhard Ecker
47.Wissenschaftliche Fortbildungswoche der Österreichischen Apothekerkammer
Conference, Poster presentation
..2014 - ..2014